nodes	percent_of_prediction	percent_of_DWPC	metapath
Eplerenone—NR3C2—Prednisolone—chronic obstructive pulmonary disease	0.232	0.674	CbGbCtD
Eplerenone—Hydrocortamate—Prednisone—chronic obstructive pulmonary disease	0.0443	0.0917	CrCrCtD
Eplerenone—Hydrocortamate—Prednisolone—chronic obstructive pulmonary disease	0.0433	0.0895	CrCrCtD
Eplerenone—Cortisone acetate—Prednisone—chronic obstructive pulmonary disease	0.043	0.0888	CrCrCtD
Eplerenone—Cortisone acetate—Prednisolone—chronic obstructive pulmonary disease	0.0419	0.0867	CrCrCtD
Eplerenone—Fluoxymesterone—Prednisolone—chronic obstructive pulmonary disease	0.0374	0.0773	CrCrCtD
Eplerenone—Fludrocortisone—Prednisone—chronic obstructive pulmonary disease	0.0373	0.0772	CrCrCtD
Eplerenone—Progesterone—Prednisolone—chronic obstructive pulmonary disease	0.0364	0.0753	CrCrCtD
Eplerenone—Fludrocortisone—Prednisolone—chronic obstructive pulmonary disease	0.0364	0.0753	CrCrCtD
Eplerenone—Methyltestosterone—Prednisone—chronic obstructive pulmonary disease	0.0364	0.0753	CrCrCtD
Eplerenone—Methyltestosterone—Prednisolone—chronic obstructive pulmonary disease	0.0355	0.0735	CrCrCtD
Eplerenone—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.0316	0.092	CbGbCtD
Eplerenone—Testosterone—Prednisolone—chronic obstructive pulmonary disease	0.0316	0.0654	CrCrCtD
Eplerenone—Hydrocortisone—Prednisone—chronic obstructive pulmonary disease	0.0304	0.0629	CrCrCtD
Eplerenone—Hydrocortisone—Prednisolone—chronic obstructive pulmonary disease	0.0297	0.0614	CrCrCtD
Eplerenone—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.0214	0.0621	CbGbCtD
Eplerenone—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.0204	0.0593	CbGbCtD
Eplerenone—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.0182	0.0528	CbGbCtD
Eplerenone—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.0107	0.031	CbGbCtD
Eplerenone—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.0101	0.0293	CbGbCtD
Eplerenone—CYP11B2—Metabolism of steroid hormones and vitamin D—GC—chronic obstructive pulmonary disease	0.0021	0.0669	CbGpPWpGaD
Eplerenone—NR3C2—ACE Inhibitor Pathway—ACE—chronic obstructive pulmonary disease	0.00202	0.0641	CbGpPWpGaD
Eplerenone—CYP11B2—ACE Inhibitor Pathway—ACE—chronic obstructive pulmonary disease	0.00165	0.0524	CbGpPWpGaD
Eplerenone—CYP3A4—Lidocaine metabolism—CYP1A2—chronic obstructive pulmonary disease	0.00128	0.0407	CbGpPWpGaD
Eplerenone—CYP3A4—Aflatoxin B1 metabolism—EPHX1—chronic obstructive pulmonary disease	0.00113	0.036	CbGpPWpGaD
Eplerenone—NR3C2—ACE Inhibitor Pathway—NOS3—chronic obstructive pulmonary disease	0.000938	0.0298	CbGpPWpGaD
Eplerenone—CYP3A4—Benzo(a)pyrene metabolism—EPHX1—chronic obstructive pulmonary disease	0.000927	0.0295	CbGpPWpGaD
Eplerenone—CYP11B2—ACE Inhibitor Pathway—NOS3—chronic obstructive pulmonary disease	0.000767	0.0244	CbGpPWpGaD
Eplerenone—NR3C2—ACE Inhibitor Pathway—TGFB1—chronic obstructive pulmonary disease	0.00062	0.0197	CbGpPWpGaD
Eplerenone—CYP11B2—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000605	0.0192	CbGpPWpGaD
Eplerenone—CYP3A7—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	0.000605	0.0192	CbGpPWpGaD
Eplerenone—CYP11B2—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000592	0.0188	CbGpPWpGaD
Eplerenone—CYP11B2—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000584	0.0186	CbGpPWpGaD
Eplerenone—CYP11B2—ACE Inhibitor Pathway—TGFB1—chronic obstructive pulmonary disease	0.000507	0.0161	CbGpPWpGaD
Eplerenone—CYP11B2—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.00048	0.0153	CbGpPWpGaD
Eplerenone—CYP3A4—Aflatoxin B1 metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000471	0.015	CbGpPWpGaD
Eplerenone—CYP3A5—Aflatoxin activation and detoxification—CYP1A2—chronic obstructive pulmonary disease	0.000455	0.0145	CbGpPWpGaD
Eplerenone—CYP3A7—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.000439	0.014	CbGpPWpGaD
Eplerenone—CYP3A5—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	0.000437	0.0139	CbGpPWpGaD
Eplerenone—CYP11B2—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.00043	0.0137	CbGpPWpGaD
Eplerenone—CYP11B2—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000424	0.0135	CbGpPWpGaD
Eplerenone—CYP3A5—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.00042	0.0134	CbGpPWpGaD
Eplerenone—CYP3A4—Aflatoxin B1 metabolism—GSTM1—chronic obstructive pulmonary disease	0.000361	0.0115	CbGpPWpGaD
Eplerenone—CYP11B2—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000349	0.0111	CbGpPWpGaD
Eplerenone—CYP3A5—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.000318	0.0101	CbGpPWpGaD
Eplerenone—CYP11B2—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000307	0.00975	CbGpPWpGaD
Eplerenone—CYP3A5—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000305	0.00971	CbGpPWpGaD
Eplerenone—CYP11B2—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000303	0.00964	CbGpPWpGaD
Eplerenone—Cardiac disorder—Salbutamol—chronic obstructive pulmonary disease	0.000296	0.00211	CcSEcCtD
Eplerenone—Flushing—Salbutamol—chronic obstructive pulmonary disease	0.000296	0.00211	CcSEcCtD
Eplerenone—Mental disorder—Formoterol—chronic obstructive pulmonary disease	0.000296	0.00211	CcSEcCtD
Eplerenone—Mental disorder—Arformoterol—chronic obstructive pulmonary disease	0.000296	0.00211	CcSEcCtD
Eplerenone—Infection—Tiotropium—chronic obstructive pulmonary disease	0.000296	0.0021	CcSEcCtD
Eplerenone—Hypotension—Aminophylline—chronic obstructive pulmonary disease	0.000295	0.0021	CcSEcCtD
Eplerenone—Malnutrition—Arformoterol—chronic obstructive pulmonary disease	0.000294	0.00209	CcSEcCtD
Eplerenone—Malnutrition—Formoterol—chronic obstructive pulmonary disease	0.000294	0.00209	CcSEcCtD
Eplerenone—Shock—Tiotropium—chronic obstructive pulmonary disease	0.000293	0.00208	CcSEcCtD
Eplerenone—Nervous system disorder—Tiotropium—chronic obstructive pulmonary disease	0.000292	0.00208	CcSEcCtD
Eplerenone—Mental disorder—Montelukast—chronic obstructive pulmonary disease	0.00029	0.00206	CcSEcCtD
Eplerenone—Angiopathy—Salbutamol—chronic obstructive pulmonary disease	0.000289	0.00206	CcSEcCtD
Eplerenone—Skin disorder—Tiotropium—chronic obstructive pulmonary disease	0.000289	0.00206	CcSEcCtD
Eplerenone—Mediastinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000288	0.00205	CcSEcCtD
Eplerenone—Insomnia—Aminophylline—chronic obstructive pulmonary disease	0.000285	0.00203	CcSEcCtD
Eplerenone—Back pain—Formoterol—chronic obstructive pulmonary disease	0.000285	0.00203	CcSEcCtD
Eplerenone—Back pain—Arformoterol—chronic obstructive pulmonary disease	0.000285	0.00203	CcSEcCtD
Eplerenone—Muscle spasms—Arformoterol—chronic obstructive pulmonary disease	0.000283	0.00201	CcSEcCtD
Eplerenone—Muscle spasms—Formoterol—chronic obstructive pulmonary disease	0.000283	0.00201	CcSEcCtD
Eplerenone—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.000281	0.002	CcSEcCtD
Eplerenone—Hypercholesterolaemia—Prednisone—chronic obstructive pulmonary disease	0.00028	0.00199	CcSEcCtD
Eplerenone—CYP3A4—Benzo(a)pyrene metabolism—CYP1A1—chronic obstructive pulmonary disease	0.00028	0.00889	CbGpPWpGaD
Eplerenone—Mental disorder—Salbutamol—chronic obstructive pulmonary disease	0.00028	0.00199	CcSEcCtD
Eplerenone—Malnutrition—Salbutamol—chronic obstructive pulmonary disease	0.000278	0.00198	CcSEcCtD
Eplerenone—Dyspepsia—Aminophylline—chronic obstructive pulmonary disease	0.000278	0.00198	CcSEcCtD
Eplerenone—Muscle spasms—Montelukast—chronic obstructive pulmonary disease	0.000277	0.00197	CcSEcCtD
Eplerenone—Flatulence—Salbutamol—chronic obstructive pulmonary disease	0.000274	0.00195	CcSEcCtD
Eplerenone—Ill-defined disorder—Arformoterol—chronic obstructive pulmonary disease	0.000273	0.00194	CcSEcCtD
Eplerenone—Ill-defined disorder—Formoterol—chronic obstructive pulmonary disease	0.000273	0.00194	CcSEcCtD
Eplerenone—Musculoskeletal discomfort—Tiotropium—chronic obstructive pulmonary disease	0.000271	0.00193	CcSEcCtD
Eplerenone—Insomnia—Tiotropium—chronic obstructive pulmonary disease	0.000269	0.00192	CcSEcCtD
Eplerenone—Angioedema—Formoterol—chronic obstructive pulmonary disease	0.000269	0.00191	CcSEcCtD
Eplerenone—Angioedema—Arformoterol—chronic obstructive pulmonary disease	0.000269	0.00191	CcSEcCtD
Eplerenone—Back pain—Salbutamol—chronic obstructive pulmonary disease	0.000269	0.00191	CcSEcCtD
Eplerenone—Muscle spasms—Salbutamol—chronic obstructive pulmonary disease	0.000267	0.0019	CcSEcCtD
Eplerenone—Malaise—Formoterol—chronic obstructive pulmonary disease	0.000265	0.00189	CcSEcCtD
Eplerenone—Malaise—Arformoterol—chronic obstructive pulmonary disease	0.000265	0.00189	CcSEcCtD
Eplerenone—Angioedema—Montelukast—chronic obstructive pulmonary disease	0.000263	0.00187	CcSEcCtD
Eplerenone—Dyspepsia—Tiotropium—chronic obstructive pulmonary disease	0.000262	0.00186	CcSEcCtD
Eplerenone—Gastrointestinal pain—Aminophylline—chronic obstructive pulmonary disease	0.000258	0.00184	CcSEcCtD
Eplerenone—Ill-defined disorder—Salbutamol—chronic obstructive pulmonary disease	0.000258	0.00183	CcSEcCtD
Eplerenone—Gastrointestinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.000257	0.00183	CcSEcCtD
Eplerenone—CYP3A7—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000257	0.00816	CbGpPWpGaD
Eplerenone—Cough—Formoterol—chronic obstructive pulmonary disease	0.000257	0.00183	CcSEcCtD
Eplerenone—Cough—Arformoterol—chronic obstructive pulmonary disease	0.000257	0.00183	CcSEcCtD
Eplerenone—CYP11B2—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.000255	0.0081	CbGpPWpGaD
Eplerenone—Constipation—Tiotropium—chronic obstructive pulmonary disease	0.000254	0.00181	CcSEcCtD
Eplerenone—Angioedema—Salbutamol—chronic obstructive pulmonary disease	0.000254	0.00181	CcSEcCtD
Eplerenone—Cough—Montelukast—chronic obstructive pulmonary disease	0.000251	0.00179	CcSEcCtD
Eplerenone—CYP11B2—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	0.000251	0.00799	CbGpPWpGaD
Eplerenone—CYP3A7—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000251	0.00798	CbGpPWpGaD
Eplerenone—Malaise—Salbutamol—chronic obstructive pulmonary disease	0.00025	0.00178	CcSEcCtD
Eplerenone—Arthralgia—Arformoterol—chronic obstructive pulmonary disease	0.00025	0.00178	CcSEcCtD
Eplerenone—Arthralgia—Formoterol—chronic obstructive pulmonary disease	0.00025	0.00178	CcSEcCtD
Eplerenone—Myalgia—Formoterol—chronic obstructive pulmonary disease	0.00025	0.00178	CcSEcCtD
Eplerenone—Chest pain—Formoterol—chronic obstructive pulmonary disease	0.00025	0.00178	CcSEcCtD
Eplerenone—Chest pain—Arformoterol—chronic obstructive pulmonary disease	0.00025	0.00178	CcSEcCtD
Eplerenone—Myalgia—Arformoterol—chronic obstructive pulmonary disease	0.00025	0.00178	CcSEcCtD
Eplerenone—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.000249	0.00178	CcSEcCtD
Eplerenone—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.000249	0.00178	CcSEcCtD
Eplerenone—Syncope—Salbutamol—chronic obstructive pulmonary disease	0.000249	0.00177	CcSEcCtD
Eplerenone—Unspecified disorder of skin and subcutaneous tissue—Arformoterol—chronic obstructive pulmonary disease	0.000249	0.00177	CcSEcCtD
Eplerenone—Unspecified disorder of skin and subcutaneous tissue—Formoterol—chronic obstructive pulmonary disease	0.000249	0.00177	CcSEcCtD
Eplerenone—CYP3A7—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000248	0.00788	CbGpPWpGaD
Eplerenone—Discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000247	0.00176	CcSEcCtD
Eplerenone—Discomfort—Formoterol—chronic obstructive pulmonary disease	0.000247	0.00176	CcSEcCtD
Eplerenone—Arthralgia—Montelukast—chronic obstructive pulmonary disease	0.000245	0.00175	CcSEcCtD
Eplerenone—Myalgia—Montelukast—chronic obstructive pulmonary disease	0.000245	0.00175	CcSEcCtD
Eplerenone—Loss of consciousness—Salbutamol—chronic obstructive pulmonary disease	0.000244	0.00174	CcSEcCtD
Eplerenone—Unspecified disorder of skin and subcutaneous tissue—Montelukast—chronic obstructive pulmonary disease	0.000244	0.00173	CcSEcCtD
Eplerenone—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.000243	0.00173	CcSEcCtD
Eplerenone—CYP3A4—Fatty Acid Omega Oxidation—CYP1A2—chronic obstructive pulmonary disease	0.000243	0.00772	CbGpPWpGaD
Eplerenone—Cough—Salbutamol—chronic obstructive pulmonary disease	0.000242	0.00173	CcSEcCtD
Eplerenone—Infection—Arformoterol—chronic obstructive pulmonary disease	0.000238	0.0017	CcSEcCtD
Eplerenone—Infection—Formoterol—chronic obstructive pulmonary disease	0.000238	0.0017	CcSEcCtD
Eplerenone—Myalgia—Salbutamol—chronic obstructive pulmonary disease	0.000236	0.00168	CcSEcCtD
Eplerenone—Chest pain—Salbutamol—chronic obstructive pulmonary disease	0.000236	0.00168	CcSEcCtD
Eplerenone—Arthralgia—Salbutamol—chronic obstructive pulmonary disease	0.000236	0.00168	CcSEcCtD
Eplerenone—Pulmonary oedema—Prednisone—chronic obstructive pulmonary disease	0.000236	0.00168	CcSEcCtD
Eplerenone—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	0.000235	0.00168	CcSEcCtD
Eplerenone—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	0.000235	0.00168	CcSEcCtD
Eplerenone—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.000235	0.00167	CcSEcCtD
Eplerenone—Discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000234	0.00166	CcSEcCtD
Eplerenone—Infection—Montelukast—chronic obstructive pulmonary disease	0.000234	0.00166	CcSEcCtD
Eplerenone—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.000233	0.00166	CcSEcCtD
Eplerenone—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.000233	0.00166	CcSEcCtD
Eplerenone—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.000231	0.00164	CcSEcCtD
Eplerenone—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.000228	0.00163	CcSEcCtD
Eplerenone—Infection—Salbutamol—chronic obstructive pulmonary disease	0.000225	0.0016	CcSEcCtD
Eplerenone—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.000224	0.0016	CcSEcCtD
Eplerenone—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.000224	0.0016	CcSEcCtD
Eplerenone—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000223	0.00159	CcSEcCtD
Eplerenone—Shock—Salbutamol—chronic obstructive pulmonary disease	0.000223	0.00159	CcSEcCtD
Eplerenone—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.000222	0.00158	CcSEcCtD
Eplerenone—CYP3A4—Estrogen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000221	0.00703	CbGpPWpGaD
Eplerenone—Diabetes mellitus—Prednisone—chronic obstructive pulmonary disease	0.000221	0.00157	CcSEcCtD
Eplerenone—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.00022	0.00157	CcSEcCtD
Eplerenone—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.000219	0.00156	CcSEcCtD
Eplerenone—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000219	0.00156	CcSEcCtD
Eplerenone—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.000219	0.00156	CcSEcCtD
Eplerenone—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.000217	0.00155	CcSEcCtD
Eplerenone—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.000217	0.00155	CcSEcCtD
Eplerenone—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000216	0.00154	CcSEcCtD
Eplerenone—CYP11B2—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	0.000216	0.00685	CbGpPWpGaD
Eplerenone—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.000214	0.00153	CcSEcCtD
Eplerenone—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.000214	0.00152	CcSEcCtD
Eplerenone—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.000214	0.00152	CcSEcCtD
Eplerenone—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.000213	0.00151	CcSEcCtD
Eplerenone—CYP11B2—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	0.000213	0.00676	CbGpPWpGaD
Eplerenone—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.000212	0.00151	CcSEcCtD
Eplerenone—CYP3A4—Aflatoxin activation and detoxification—CYP1A2—chronic obstructive pulmonary disease	0.000212	0.00673	CbGpPWpGaD
Eplerenone—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.000211	0.0015	CcSEcCtD
Eplerenone—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.000211	0.0015	CcSEcCtD
Eplerenone—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.00021	0.0015	CcSEcCtD
Eplerenone—CYP11B2—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	0.00021	0.00667	CbGpPWpGaD
Eplerenone—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000209	0.00149	CcSEcCtD
Eplerenone—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000207	0.00148	CcSEcCtD
Eplerenone—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000207	0.00148	CcSEcCtD
Eplerenone—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.000207	0.00147	CcSEcCtD
Eplerenone—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.000207	0.00147	CcSEcCtD
Eplerenone—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.000207	0.00147	CcSEcCtD
Eplerenone—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000207	0.00147	CcSEcCtD
Eplerenone—Pain—Arformoterol—chronic obstructive pulmonary disease	0.000205	0.00146	CcSEcCtD
Eplerenone—Pain—Formoterol—chronic obstructive pulmonary disease	0.000205	0.00146	CcSEcCtD
Eplerenone—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.000205	0.00146	CcSEcCtD
Eplerenone—Constipation—Formoterol—chronic obstructive pulmonary disease	0.000205	0.00146	CcSEcCtD
Eplerenone—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.000205	0.00146	CcSEcCtD
Eplerenone—CYP3A7—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000203	0.00647	CbGpPWpGaD
Eplerenone—CYP3A4—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	0.000203	0.00646	CbGpPWpGaD
Eplerenone—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000203	0.00145	CcSEcCtD
Eplerenone—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.000203	0.00144	CcSEcCtD
Eplerenone—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.000202	0.00144	CcSEcCtD
Eplerenone—Pain—Montelukast—chronic obstructive pulmonary disease	0.000201	0.00143	CcSEcCtD
Eplerenone—Acute coronary syndrome—Prednisolone—chronic obstructive pulmonary disease	0.000201	0.00143	CcSEcCtD
Eplerenone—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000201	0.00143	CcSEcCtD
Eplerenone—Myocardial infarction—Prednisolone—chronic obstructive pulmonary disease	0.0002	0.00142	CcSEcCtD
Eplerenone—Neuropathy peripheral—Prednisolone—chronic obstructive pulmonary disease	0.0002	0.00142	CcSEcCtD
Eplerenone—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.0002	0.00142	CcSEcCtD
Eplerenone—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000199	0.00142	CcSEcCtD
Eplerenone—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000199	0.00141	CcSEcCtD
Eplerenone—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000198	0.00141	CcSEcCtD
Eplerenone—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000198	0.00141	CcSEcCtD
Eplerenone—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000198	0.00141	CcSEcCtD
Eplerenone—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000197	0.0014	CcSEcCtD
Eplerenone—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.000196	0.0014	CcSEcCtD
Eplerenone—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.000196	0.0014	CcSEcCtD
Eplerenone—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000196	0.00139	CcSEcCtD
Eplerenone—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.000195	0.00139	CcSEcCtD
Eplerenone—CYP3A4—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000195	0.00621	CbGpPWpGaD
Eplerenone—CYP11B2—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	0.000195	0.00621	CbGpPWpGaD
Eplerenone—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.000194	0.00138	CcSEcCtD
Eplerenone—Pain—Salbutamol—chronic obstructive pulmonary disease	0.000194	0.00138	CcSEcCtD
Eplerenone—CYP11B2—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	0.000193	0.00613	CbGpPWpGaD
Eplerenone—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.000192	0.00137	CcSEcCtD
Eplerenone—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.00019	0.00135	CcSEcCtD
Eplerenone—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.00019	0.00135	CcSEcCtD
Eplerenone—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.00019	0.00135	CcSEcCtD
Eplerenone—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.00019	0.00135	CcSEcCtD
Eplerenone—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000189	0.00135	CcSEcCtD
Eplerenone—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000188	0.00134	CcSEcCtD
Eplerenone—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000187	0.00133	CcSEcCtD
Eplerenone—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000187	0.00133	CcSEcCtD
Eplerenone—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000187	0.00133	CcSEcCtD
Eplerenone—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000186	0.00133	CcSEcCtD
Eplerenone—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.000186	0.00132	CcSEcCtD
Eplerenone—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000186	0.00132	CcSEcCtD
Eplerenone—CYP3A5—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000186	0.0059	CbGpPWpGaD
Eplerenone—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000185	0.00132	CcSEcCtD
Eplerenone—CYP11B2—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	0.000185	0.00589	CbGpPWpGaD
Eplerenone—CYP11B2—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	0.000183	0.00581	CbGpPWpGaD
Eplerenone—CYP3A7—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000182	0.0058	CbGpPWpGaD
Eplerenone—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000181	0.00577	CbGpPWpGaD
Eplerenone—CYP3A7—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.00018	0.00572	CbGpPWpGaD
Eplerenone—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.000179	0.00128	CcSEcCtD
Eplerenone—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000179	0.00128	CcSEcCtD
Eplerenone—CYP3A5—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000179	0.00569	CbGpPWpGaD
Eplerenone—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000177	0.00126	CcSEcCtD
Eplerenone—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—chronic obstructive pulmonary disease	0.000176	0.00561	CbGpPWpGaD
Eplerenone—Hypokalaemia—Prednisone—chronic obstructive pulmonary disease	0.000175	0.00125	CcSEcCtD
Eplerenone—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000172	0.00123	CcSEcCtD
Eplerenone—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000172	0.00123	CcSEcCtD
Eplerenone—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.00017	0.00121	CcSEcCtD
Eplerenone—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.00017	0.00121	CcSEcCtD
Eplerenone—Alanine aminotransferase increased—Prednisone—chronic obstructive pulmonary disease	0.00017	0.00121	CcSEcCtD
Eplerenone—CYP3A4—Estrogen metabolism—GSTM1—chronic obstructive pulmonary disease	0.000169	0.00539	CbGpPWpGaD
Eplerenone—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000169	0.0012	CcSEcCtD
Eplerenone—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000166	0.00118	CcSEcCtD
Eplerenone—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000164	0.00117	CcSEcCtD
Eplerenone—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000164	0.00117	CcSEcCtD
Eplerenone—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000163	0.00116	CcSEcCtD
Eplerenone—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000161	0.00115	CcSEcCtD
Eplerenone—CYP3A4—Estrogen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000161	0.00511	CbGpPWpGaD
Eplerenone—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.00016	0.00114	CcSEcCtD
Eplerenone—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000159	0.00113	CcSEcCtD
Eplerenone—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000159	0.00113	CcSEcCtD
Eplerenone—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000155	0.00111	CcSEcCtD
Eplerenone—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000155	0.0011	CcSEcCtD
Eplerenone—NR3C2—Generic Transcription Pathway—CTGF—chronic obstructive pulmonary disease	0.000155	0.00491	CbGpPWpGaD
Eplerenone—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000153	0.00109	CcSEcCtD
Eplerenone—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000153	0.00109	CcSEcCtD
Eplerenone—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000151	0.00108	CcSEcCtD
Eplerenone—Rash—Formoterol—chronic obstructive pulmonary disease	0.000151	0.00108	CcSEcCtD
Eplerenone—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000151	0.00108	CcSEcCtD
Eplerenone—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000151	0.00108	CcSEcCtD
Eplerenone—Headache—Arformoterol—chronic obstructive pulmonary disease	0.00015	0.00107	CcSEcCtD
Eplerenone—Headache—Formoterol—chronic obstructive pulmonary disease	0.00015	0.00107	CcSEcCtD
Eplerenone—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.00015	0.00107	CcSEcCtD
Eplerenone—Hyperglycaemia—Prednisone—chronic obstructive pulmonary disease	0.00015	0.00107	CcSEcCtD
Eplerenone—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000149	0.00106	CcSEcCtD
Eplerenone—CYP11B2—Metabolism—APIP—chronic obstructive pulmonary disease	0.000149	0.00474	CbGpPWpGaD
Eplerenone—Rash—Montelukast—chronic obstructive pulmonary disease	0.000148	0.00106	CcSEcCtD
Eplerenone—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000148	0.00105	CcSEcCtD
Eplerenone—CYP3A7—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000148	0.0047	CbGpPWpGaD
Eplerenone—Ill-defined disorder—Prednisolone—chronic obstructive pulmonary disease	0.000148	0.00105	CcSEcCtD
Eplerenone—Depression—Prednisone—chronic obstructive pulmonary disease	0.000148	0.00105	CcSEcCtD
Eplerenone—CYP3A4—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.000148	0.00469	CbGpPWpGaD
Eplerenone—Headache—Montelukast—chronic obstructive pulmonary disease	0.000147	0.00105	CcSEcCtD
Eplerenone—CYP3A5—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000147	0.00468	CbGpPWpGaD
Eplerenone—Acute coronary syndrome—Prednisone—chronic obstructive pulmonary disease	0.000146	0.00104	CcSEcCtD
Eplerenone—Angioedema—Prednisolone—chronic obstructive pulmonary disease	0.000146	0.00104	CcSEcCtD
Eplerenone—Myocardial infarction—Prednisone—chronic obstructive pulmonary disease	0.000145	0.00103	CcSEcCtD
Eplerenone—Neuropathy peripheral—Prednisone—chronic obstructive pulmonary disease	0.000145	0.00103	CcSEcCtD
Eplerenone—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000144	0.00103	CcSEcCtD
Eplerenone—Malaise—Prednisolone—chronic obstructive pulmonary disease	0.000144	0.00102	CcSEcCtD
Eplerenone—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000143	0.00102	CcSEcCtD
Eplerenone—Syncope—Prednisolone—chronic obstructive pulmonary disease	0.000143	0.00102	CcSEcCtD
Eplerenone—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000143	0.00102	CcSEcCtD
Eplerenone—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000143	0.00102	CcSEcCtD
Eplerenone—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000143	0.00102	CcSEcCtD
Eplerenone—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000142	0.00101	CcSEcCtD
Eplerenone—CYP3A4—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000142	0.00451	CbGpPWpGaD
Eplerenone—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	0.00014	0.000997	CcSEcCtD
Eplerenone—Nausea—Montelukast—chronic obstructive pulmonary disease	0.00014	0.000994	CcSEcCtD
Eplerenone—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000135	0.000959	CcSEcCtD
Eplerenone—Discomfort—Prednisolone—chronic obstructive pulmonary disease	0.000134	0.000954	CcSEcCtD
Eplerenone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	0.000133	0.00422	CbGpPWpGaD
Eplerenone—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000132	0.00419	CbGpPWpGaD
Eplerenone—Connective tissue disorder—Prednisone—chronic obstructive pulmonary disease	0.000131	0.00093	CcSEcCtD
Eplerenone—Progesterone—CYP1A1—chronic obstructive pulmonary disease	0.00013	0.23	CrCbGaD
Eplerenone—CYP3A5—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.00013	0.00414	CbGpPWpGaD
Eplerenone—CYP3A7—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.00013	0.00413	CbGpPWpGaD
Eplerenone—CYP3A7—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000129	0.00409	CbGpPWpGaD
Eplerenone—Shock—Prednisolone—chronic obstructive pulmonary disease	0.000128	0.000911	CcSEcCtD
Eplerenone—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	0.000126	0.000895	CcSEcCtD
Eplerenone—Progesterone—CYP1A2—chronic obstructive pulmonary disease	0.000126	0.222	CrCbGaD
Eplerenone—Flushing—Prednisone—chronic obstructive pulmonary disease	0.000123	0.000879	CcSEcCtD
Eplerenone—Testosterone—CYP1A1—chronic obstructive pulmonary disease	0.000123	0.218	CrCbGaD
Eplerenone—Angiopathy—Prednisone—chronic obstructive pulmonary disease	0.000121	0.000859	CcSEcCtD
Eplerenone—Methyltestosterone—ALB—chronic obstructive pulmonary disease	0.000118	0.209	CrCbGaD
Eplerenone—Insomnia—Prednisolone—chronic obstructive pulmonary disease	0.000118	0.000837	CcSEcCtD
Eplerenone—Mental disorder—Prednisone—chronic obstructive pulmonary disease	0.000116	0.00083	CcSEcCtD
Eplerenone—Malnutrition—Prednisone—chronic obstructive pulmonary disease	0.000116	0.000824	CcSEcCtD
Eplerenone—Pain—Prednisolone—chronic obstructive pulmonary disease	0.000111	0.000792	CcSEcCtD
Eplerenone—CYP3A7—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.000108	0.00344	CbGpPWpGaD
Eplerenone—Ill-defined disorder—Prednisone—chronic obstructive pulmonary disease	0.000107	0.000765	CcSEcCtD
Eplerenone—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.000107	0.000763	CcSEcCtD
Eplerenone—Anaemia—Prednisone—chronic obstructive pulmonary disease	0.000107	0.000762	CcSEcCtD
Eplerenone—CYP3A5—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000107	0.0034	CbGpPWpGaD
Eplerenone—CYP3A7—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	0.000107	0.00339	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	0.000106	0.00338	CbGpPWpGaD
Eplerenone—Angioedema—Prednisone—chronic obstructive pulmonary disease	0.000106	0.000753	CcSEcCtD
Eplerenone—Malaise—Prednisone—chronic obstructive pulmonary disease	0.000104	0.000743	CcSEcCtD
Eplerenone—CYP3A4—Tryptophan metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000104	0.00332	CbGpPWpGaD
Eplerenone—Syncope—Prednisone—chronic obstructive pulmonary disease	0.000104	0.000739	CcSEcCtD
Eplerenone—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	0.000102	0.000724	CcSEcCtD
Eplerenone—CYP11B2—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	9.87e-05	0.00314	CbGpPWpGaD
Eplerenone—Arthralgia—Prednisone—chronic obstructive pulmonary disease	9.85e-05	0.000702	CcSEcCtD
Eplerenone—Myalgia—Prednisone—chronic obstructive pulmonary disease	9.85e-05	0.000702	CcSEcCtD
Eplerenone—CYP11B2—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	9.79e-05	0.00311	CbGpPWpGaD
Eplerenone—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	9.79e-05	0.000697	CcSEcCtD
Eplerenone—Discomfort—Prednisone—chronic obstructive pulmonary disease	9.74e-05	0.000693	CcSEcCtD
Eplerenone—CYP11B2—Metabolism—GC—chronic obstructive pulmonary disease	9.6e-05	0.00305	CbGpPWpGaD
Eplerenone—CYP3A5—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	9.4e-05	0.00299	CbGpPWpGaD
Eplerenone—Infection—Prednisone—chronic obstructive pulmonary disease	9.39e-05	0.000668	CcSEcCtD
Eplerenone—Shock—Prednisone—chronic obstructive pulmonary disease	9.29e-05	0.000662	CcSEcCtD
Eplerenone—CYP3A5—Biological oxidations—GCLC—chronic obstructive pulmonary disease	9.29e-05	0.00295	CbGpPWpGaD
Eplerenone—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	9.26e-05	0.00066	CcSEcCtD
Eplerenone—Skin disorder—Prednisone—chronic obstructive pulmonary disease	9.18e-05	0.000653	CcSEcCtD
Eplerenone—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	9.13e-05	0.00065	CcSEcCtD
Eplerenone—CYP3A7—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	9.02e-05	0.00287	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	8.93e-05	0.00284	CbGpPWpGaD
Eplerenone—CYP3A7—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	8.89e-05	0.00283	CbGpPWpGaD
Eplerenone—CYP3A4—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	8.63e-05	0.00274	CbGpPWpGaD
Eplerenone—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	8.61e-05	0.000613	CcSEcCtD
Eplerenone—Dizziness—Prednisolone—chronic obstructive pulmonary disease	8.6e-05	0.000612	CcSEcCtD
Eplerenone—Insomnia—Prednisone—chronic obstructive pulmonary disease	8.54e-05	0.000608	CcSEcCtD
Eplerenone—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	8.44e-05	0.00268	CbGpPWpGaD
Eplerenone—CYP3A4—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	8.33e-05	0.00265	CbGpPWpGaD
Eplerenone—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	8.32e-05	0.000592	CcSEcCtD
Eplerenone—CYP3A7—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	8.28e-05	0.00263	CbGpPWpGaD
Eplerenone—Rash—Prednisolone—chronic obstructive pulmonary disease	8.2e-05	0.000584	CcSEcCtD
Eplerenone—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	8.19e-05	0.000583	CcSEcCtD
Eplerenone—CYP3A7—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	8.17e-05	0.0026	CbGpPWpGaD
Eplerenone—Fatigue—Prednisone—chronic obstructive pulmonary disease	8.14e-05	0.00058	CcSEcCtD
Eplerenone—Headache—Prednisolone—chronic obstructive pulmonary disease	8.14e-05	0.00058	CcSEcCtD
Eplerenone—Constipation—Prednisone—chronic obstructive pulmonary disease	8.08e-05	0.000575	CcSEcCtD
Eplerenone—CYP3A7—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	7.85e-05	0.0025	CbGpPWpGaD
Eplerenone—CYP3A5—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	7.81e-05	0.00248	CbGpPWpGaD
Eplerenone—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	7.78e-05	0.000554	CcSEcCtD
Eplerenone—CYP3A7—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	7.75e-05	0.00246	CbGpPWpGaD
Eplerenone—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	7.73e-05	0.00055	CcSEcCtD
Eplerenone—Nausea—Prednisolone—chronic obstructive pulmonary disease	7.72e-05	0.00055	CcSEcCtD
Eplerenone—CYP3A5—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	7.71e-05	0.00245	CbGpPWpGaD
Eplerenone—CYP3A4—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	7.58e-05	0.00241	CbGpPWpGaD
Eplerenone—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	7.47e-05	0.000532	CcSEcCtD
Eplerenone—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	7.47e-05	0.000532	CcSEcCtD
Eplerenone—NR3C2—Gene Expression—CTGF—chronic obstructive pulmonary disease	7.44e-05	0.00237	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	7.11e-05	0.00226	CbGpPWpGaD
Eplerenone—NR3C2—Generic Transcription Pathway—SERPINE1—chronic obstructive pulmonary disease	7.05e-05	0.00224	CbGpPWpGaD
Eplerenone—NR3C2—Gene Expression—HDAC2—chronic obstructive pulmonary disease	6.93e-05	0.0022	CbGpPWpGaD
Eplerenone—Testosterone—ALB—chronic obstructive pulmonary disease	6.85e-05	0.121	CrCbGaD
Eplerenone—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	6.84e-05	0.00217	CbGpPWpGaD
Eplerenone—Asthenia—Prednisone—chronic obstructive pulmonary disease	6.78e-05	0.000483	CcSEcCtD
Eplerenone—Pruritus—Prednisone—chronic obstructive pulmonary disease	6.68e-05	0.000476	CcSEcCtD
Eplerenone—CYP3A5—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	6.52e-05	0.00207	CbGpPWpGaD
Eplerenone—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	6.46e-05	0.00046	CcSEcCtD
Eplerenone—CYP3A5—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	6.43e-05	0.00204	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—APIP—chronic obstructive pulmonary disease	6.32e-05	0.00201	CbGpPWpGaD
Eplerenone—Dizziness—Prednisone—chronic obstructive pulmonary disease	6.25e-05	0.000445	CcSEcCtD
Eplerenone—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	6.13e-05	0.00195	CbGpPWpGaD
Eplerenone—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	6.05e-05	0.00192	CbGpPWpGaD
Eplerenone—Vomiting—Prednisone—chronic obstructive pulmonary disease	6.01e-05	0.000428	CcSEcCtD
Eplerenone—CYP3A5—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	5.99e-05	0.0019	CbGpPWpGaD
Eplerenone—Rash—Prednisone—chronic obstructive pulmonary disease	5.96e-05	0.000424	CcSEcCtD
Eplerenone—Dermatitis—Prednisone—chronic obstructive pulmonary disease	5.95e-05	0.000424	CcSEcCtD
Eplerenone—Headache—Prednisone—chronic obstructive pulmonary disease	5.92e-05	0.000421	CcSEcCtD
Eplerenone—CYP3A5—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	5.91e-05	0.00188	CbGpPWpGaD
Eplerenone—CYP3A5—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	5.68e-05	0.0018	CbGpPWpGaD
Eplerenone—Nausea—Prednisone—chronic obstructive pulmonary disease	5.61e-05	0.0004	CcSEcCtD
Eplerenone—CYP3A5—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	5.6e-05	0.00178	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—GSTT1—chronic obstructive pulmonary disease	5.25e-05	0.00167	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—GCLC—chronic obstructive pulmonary disease	5.18e-05	0.00165	CbGpPWpGaD
Eplerenone—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	4.97e-05	0.00158	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	4.83e-05	0.00154	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—CTGF—chronic obstructive pulmonary disease	4.73e-05	0.0015	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—APIP—chronic obstructive pulmonary disease	4.57e-05	0.00145	CbGpPWpGaD
Eplerenone—CYP3A4—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	4.37e-05	0.00139	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—CYP1A2—chronic obstructive pulmonary disease	4.36e-05	0.00139	CbGpPWpGaD
Eplerenone—CYP3A4—Biological oxidations—GCLC—chronic obstructive pulmonary disease	4.32e-05	0.00137	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	4.19e-05	0.00133	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—GC—chronic obstructive pulmonary disease	4.07e-05	0.00129	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	3.79e-05	0.0012	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—GSTP1—chronic obstructive pulmonary disease	3.64e-05	0.00116	CbGpPWpGaD
Eplerenone—CYP3A4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	3.63e-05	0.00115	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—HMOX1—chronic obstructive pulmonary disease	3.59e-05	0.00114	CbGpPWpGaD
Eplerenone—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	3.58e-05	0.00114	CbGpPWpGaD
Eplerenone—NR3C2—Gene Expression—SERPINE1—chronic obstructive pulmonary disease	3.39e-05	0.00108	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—GSTM1—chronic obstructive pulmonary disease	3.34e-05	0.00106	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	3.17e-05	0.00101	CbGpPWpGaD
Eplerenone—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	3.03e-05	0.000963	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.03e-05	0.000962	CbGpPWpGaD
Eplerenone—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	2.99e-05	0.00095	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—GC—chronic obstructive pulmonary disease	2.94e-05	0.000936	CbGpPWpGaD
Eplerenone—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	2.78e-05	0.000885	CbGpPWpGaD
Eplerenone—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	2.75e-05	0.000873	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.74e-05	0.00087	CbGpPWpGaD
Eplerenone—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	2.64e-05	0.000839	CbGpPWpGaD
Eplerenone—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	2.6e-05	0.000828	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.22e-05	0.000707	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—GCLC—chronic obstructive pulmonary disease	2.2e-05	0.000699	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—ALB—chronic obstructive pulmonary disease	2.15e-05	0.000684	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	2.12e-05	0.000675	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—NOS3—chronic obstructive pulmonary disease	2.06e-05	0.000655	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—CTGF—chronic obstructive pulmonary disease	2.01e-05	0.000638	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.85e-05	0.000588	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.61e-05	0.000511	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—GCLC—chronic obstructive pulmonary disease	1.59e-05	0.000505	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.54e-05	0.00049	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.52e-05	0.000483	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—CTGF—chronic obstructive pulmonary disease	1.45e-05	0.000461	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.42e-05	0.00045	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.41e-05	0.000447	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	1.37e-05	0.000435	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.34e-05	0.000427	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.34e-05	0.000425	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.27e-05	0.000404	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.11e-05	0.000354	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.1e-05	0.000349	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.02e-05	0.000326	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—CYP1A1—chronic obstructive pulmonary disease	9.71e-06	0.000309	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—ALB—chronic obstructive pulmonary disease	9.13e-06	0.00029	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—NOS3—chronic obstructive pulmonary disease	8.73e-06	0.000278	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	7.48e-06	0.000238	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	7.39e-06	0.000235	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	6.74e-06	0.000214	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—ALB—chronic obstructive pulmonary disease	6.6e-06	0.00021	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—NOS3—chronic obstructive pulmonary disease	6.31e-06	0.000201	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	6.21e-06	0.000197	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	5.18e-06	0.000165	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	5.11e-06	0.000162	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	4.76e-06	0.000151	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	4.51e-06	0.000143	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	3.07e-06	9.75e-05	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	2.93e-06	9.33e-05	CbGpPWpGaD
